日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors

特发性 CD4+ 淋巴细胞减少症:自然病史和预后因素

Dimitrios I Zonios, Judith Falloon, John E Bennett, Pamela A Shaw, Doreen Chaitt, Michael W Baseler, Joseph W Adelsberger, Julia A Metcalf, Michael A Polis, Stephen B Kovacs, Joseph A Kovacs, Richard T Davey, H Clifford Lane, Henry Masur, Irini Sereti

Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7

特发性CD4+ T淋巴细胞减少症与未成熟/过渡性B细胞增多和血清IL-7水平升高有关。

Malaspina, Angela; Moir, Susan; Chaitt, Doreen G; Rehm, Catherine A; Kottilil, Shyam; Falloon, Judith; Fauci, Anthony S

Randomized, controlled phase I/II, trial of combination therapy with delavirdine (U-90152S) and conventional nucleosides in human immunodeficiency virus type 1-infected patients

一项随机、对照的 I/II 期临床试验,研究地拉韦啶 (U-90152S) 与传统核苷类药物联合治疗 1 型人类免疫缺陷病毒感染患者的疗效。

Davey, R T Jr; Chaitt, D G; Reed, G F; Freimuth, W W; Herpin, B R; Metcalf, J A; Eastman, P S; Falloon, J; Kovacs, J A; Polis, M A; Walker, R E; Masur, H; Boyle, J; Coleman, S; Cox, S R; Wathen, L; Daenzer, C L; Lane, H C